Granulocyte colony-stimulating factor use in a large British hospital: comparison with published experience
Granulocyte colony-stimulating factors (G-CSF) are high-cost agents recommended as prophylaxis of febrile neutropenia or as adjunctive treatment of severe neutropenic sepsis. Their use in high-risk situations such as acute myeloid leukaemia, acute lymphocytic leukaemia, myelodysplastic syndrome and...
Saved in:
Main Author: | Pérez Velasco R (Author) |
---|---|
Format: | Book |
Published: |
Centro de Investigaciones y Publicaciones Farmaceuticas,
2010-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Granulocyte colony-stimulating factor and leukemogenesis
by: Lorena Lobo de Figueiredo, et al.
Published: (2004) -
Granulocyte Colony-Stimulating Factor in Amniotic Fluid
by: B. Denise Raynor, et al.
Published: (1995) -
Granulocyte colony-stimulating factor and reproductive medicine: A review
by: Marcelo Borges Cavalcante, et al.
Published: (2015) -
Use of granulocyte colony-stimulating factor in patients with chemotherapy-induced neutropaenia
by: Lucky L. Shokane, et al.
Published: (2023) -
Contrasting Immunopathogenic and Therapeutic Roles of Granulocyte Colony-Stimulating Factor in Cancer
by: Annette J. Theron, et al.
Published: (2020)